This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Looking at the future use of Recor Medical and Medtronic's ultrasound renal denervation (RDN) systems for patients with resistant hypertension

Ticker(s): MDT, OTSKY, ReCor Medical

Who's the expert?

Institution: The University of Tennessee College of Medicine

  • Assistant Professor at the University of Tennessee College of Medicine, Co-Director of complex coronary intervention & Chairs the Interventional Cardiology Chronic Total Occlusion Affinity Group at Ascension Saint Thomas Hospital.
  • Has treated ~30 patients with mitral regurgitation using MitraClip.
  • Clinical and research focus on the management of complex coronary disease, including chronic total occlusions, imaging, physiology, peripheral arterial revascularization, cardiogenic shock, and management of pulmonary embolism.

Interview Questions
Q1.

Please describe your background and patient setting

Added By: ben_admin
Q2.

How many patients with resistant hypertension do you manage?

Added By: ben_admin
Q3.

Do you plan to utilize RDN systems in practice?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.